Gastroretentive Drug Delivery Systems Outsourcing Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theGastroretentive Drug Delivery Systems Outsourcing Market?
The gastroretentive drug delivery systems outsourcing market is anticipated to be fueled by the increasing instances of gastrointestinal diseases. The term gastrointestinal disorders relates to a broad spectrum of ailments impacting the digestive system, including the organs such as the stomach, liver, gallbladder, intestines, and pancreas. Factors such as an aging population, use of antibiotics, infectious pathogens, changes in diet, stress, lifestyle habits, and obesity are leading to an increase in gastrointestinal disorders. Pharmaceutical firms are resorting to outsourcing gastroretentive drug delivery systems, as it grants them the necessary tools and expertise to handle the escalating burden of these disorders, thereby enhancing patient results and life quality. In the context of growing gastrointestinal disorder cases, for example, the American Cancer Society (ACS), a US-based organization committed to combating cancer, reported that gastrointestinal cancers rose by 3.18% to 348,840 from 338,090 in 2021 in the U.S. in January 2023. Hence, the growing instances of gastrointestinal disorders are pushing the growth of the gastroretentive drug delivery systems outsourcing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp
#What Growth Opportunities Will Drive the Gastroretentive Drug Delivery Systems Outsourcing Market’s CAGR Through 2034?
The market size for outsourced gastroretentive drug delivery systems has seen significant expansion lately. The market’s growth is projected to rise from $1.39 billion in 2024 to $1.5 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.3%. Factors such as an increase in stomach and small intestine diseases, the development of drug delivery systems, growing cases of gastric cancer, governmental initiatives, and the rising number of hospitals contributed to the historical period’s growth.
The market for outsourced gastroretentive drug delivery systems is anticipated to witness robust growth in the coming years, reaching $2.03 billion in 2029 with a compounded annual growth rate of 7.9%. This upcoming growth has been attributed to the increase in ambulatory centers, greater focus on patient compliance and comfort, a surge in chronic diseases, a rise in individualized care, and an increasing aging populace. Key trends during this period are expected to be advancements in polymer science, bioadhesive systems, new polymers, drug release modifiers, and the creation of gastroretentive dosage tactics. Other major predictors include the adoption of digital health technology, intelligent gastroretentive systems, and targeted drug delivery methods.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813
Which Upcoming Market Trends and Innovations Are Set to Influence theGastroretentive Drug Delivery Systems Outsourcing Market’s Path Forward?
Leading enterprises in the gastroretentive drug delivery systems outsourcing market are honing their focus on creating pioneering products like ready-to-fill (RTF) colon functional capsules to boost drug delivery efficacy and patient comfort. This refers to ready-made, unfilled capsules, specifically created to be packed with specific drugs or active components intended for the colon. As an illustration, Evonik, a proficient drug delivery organization from Germany, unveiled their EUDRACAP colon functional capsules in September 2024 for targeted oral drug delivery to the ileo-colonic area. These trailblazing capsules are the maiden ready-to-fill option in the market, with the aim of delivering delicate active components such as live biotherapeutic products (LBPs). Currently sold in technical grade, a GMP-grade variant is also under progression. EUDRACAP colon augments the oral drug development process by easing formulation and expediting market penetration, making it a significant leap in gastroretentive drug delivery systems.
Who Are the Dominant Market Players Pushing the Boundaries of theGastroretentive Drug Delivery Systems Outsourcing Market?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.
Order Your Report Now For A Swift Delivery:
What Are the Core Segments of the Gastroretentive Drug Delivery Systems Outsourcing Market, and How Do They Contribute to Growth?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented –
1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) Floating Systems: Single Unit Systems, Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15813&type=smp
What Regions Are Dominating the Gastroretentive Drug Delivery Systems Outsourcing Market Growth?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Gastroretentive Drug Delivery Systems Outsourcing Market 2025, By The Business Research Company:
Nasal Drug Delivery Technology Global Market Report 2024
Gastrointestinal Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report
Connected Drug Delivery Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
